Another panel of 5 markers, consisting of S100B, vWF, MMP9, B-type neurotrophic growth factor (BNGF), and monocyte chemoattractant protein 1 (MCP1), can distinguish patients with ischemic stroke from healthy controls with 92% sensitivity and 93% specificity [25–27]. Here, CCL2 is linked to ischemic stroke.